Manifestaciones dermatológicas por Covid-19 y su aporte en la comprensión de la enfermedad

Autores/as

DOI:

https://doi.org/10.29176/2590843X.1641

Palabras clave:

Cabello, Enfermedad por coronavirus 2019-nCoV, Eritema pernio, Exantema, Fisiopatología, Livedo reticular, Manifestaciones cutáneas, Mucosa oral, Piel, Púrpura, Uñas, Urticaria, Vesícula

Resumen

La enfermedad por coronavirus (Covid-19) presenta compromiso multisistémico y hasta en el 20% de los casos puede exhibir signos dermatológicos. Se realiza una revisión narrativa de la literatura acerca de las principales manifestaciones mucocutáneas asociadas a la infección por Covid-19. También se describen brevemente los mecanismos fisiopatológicos y se lleva a cabo una clasificación de las lesiones en maculopapulares, urticariales, vesiculoampollosas, tipo pernio, livedo necróticas, vasculíticas, con compromiso del folículo piloso, ungular u oral. Se presentan sus principales características clínicas, histopatológicas y tratamientos.

Biografía del autor/a

Heliana Botello, Universidad de Caldas: Manizales, Caldas, CO

Médica Dermatóloga, Coordinadora Semillero de Investigación en Dermatología (SIDERM) , Universidad de Caldas.

Adriana Zamudio Barrientos, Universidad de Cartagena: Cartagena, Bolivar, CO

Residente de Tercer año de dermatología, Universidad de Cartagena.

Manuel Eduardo Gahona Naranjo, Pontificia Universidad Javeriana: Bogotá, Cundinamarca, CO

Médico general, Pontificia Universidad Javeriana.

Referencias bibliográficas

Singh H, Kaur H, Singh K, Sen CK. Cutaneous manifestations of COVID-19: A systematic review. Advances in Wound Care. 2021;10(2):51-80. https://doi.org/10.1089/wound.2020.1309

Perlman S. Another Decade, Another Coronavirus. N Engl J Med. 2020;382(8):760-2. https://doi.org/10.1056/nejme2001126

Millán-Oñate J, Rodriguez-Morales AJ, Camacho-Moreno G, Mendoza-Ramírez H. A new emerging zoonotic virus of concern : the 2019 novel Coronavirus (SARS CoV-2 ). Infectio. 2021;24(3):187-92.

Zhou P, Yang X, Wang XG, Hu B, Zhang L, Zhang W, et al. A pneumonia outbreak associated with a new coronavirus of probable bat origin. Nature. 2020;579(7798):270-3. https://doi.org/10.1038/s41586-020-2012-7

Wu Z, McGoogan JM. Characteristics of and Important Lessons From the Coronavirus Disease 2019 (COVID-19) Outbreak in China. JAMA. 2020;323(13):1239. https://doi.org/10.1001/jama.2020.2648

Guan W, Ni Z, Hu Y, et al. Clinical Characteristics of Coronavirus Disease 2019 in China. N Engl J Med. 2020;382(18):1708-20. https://doi.org/10.1056/nejmoa2002032

Tammaro A, Adebanjo GAR, Parisella FR, Pezzuto A, Rello J. Cutaneous manifestations in COVID-19: the experiences of Barcelona and Rome. J Eur Acad Dermatol Venereol. 2020;34(7):e306-e307. https://doi.org/10.1111/jdv.16530

Fernandez-Nieto D, Ortega-Quijano D, Segurado-Miravalles G, Pindado-Ortega C, Prieto-Barrios M, Jimenez-Cauhe J. Comment on: Cutaneous manifestations in COVID-19: a first perspective. Safety concerns of clinical images and skin biopsies. J Eur Acad Dermatol Venereol. 2020;34(6):e252-e254. https://doi.org/10.1111/jdv.16470

Galván C, Català A, Carretero G, Rodríguez P, Fernández D, Rodríguez A, et al. Classification of the cutaneous manifestations of COVID-19: a rapid prospective nationwide consensus study in Spain with 375 cases. Br J Dermatol. 2020;183(1):71-7. https://doi.org/10.1111/bjd.19163

Ortega-Quijano D, Jimenez-Cauhe J, Selda-Enriquez G, Fernandez-Guarino M, Fernandez-Nieto D. Algorithm for the classification of COVID-19 rashes. J Am Acad Dermatol. 2020;83(2):e103-e104. https://doi.org/10.1016/j.jaad.2020.05.034

Freeman EE, McMahon DE, Lipoff JB, Thiers B, Hruza G, Fox L, et al. The spectrum of COVID-19-associated dermatologic manifestations: An international registry of 716 patients from 31 countries. J Am Acad Dermatol. 2020;83(4):1118-29. https://doi.org/10.1016/j.jaad.2020.06.1016

Carrascosa JM, Morillas V, Bielsa I, Munera-Campos M. Cutaneous Manifestations in the Context of SARS-CoV-2 Infection (COVID-19). Actas Dermo-Sifiliograficas. 2020;111(9):734-43. https://doi.org/10.1016/j.ad.2020.08.002

Pastrian-Soto G, Pastrian-Soto G. Bases Genéticas y Moleculares del COVID-19 (SARS-CoV-2). Mecanismos de Patogénesis y de Respuesta Inmune. Int J Odontostomatol. 2020;14(3):331-7. https://doi.org/10.4067/S0718-381X2020000300331

Magro C, Mulvey JJ, Berlin D, Nuovo G, Salvatore S, Harp J, et al. Complement associated microvascular injury and thrombosis in the pathogenesis of severe COVID-19 infection: A report of five cases. Trans Research. 2020;220:1-13. https://doi.org/10.1016/j.trsl.2020.04.007

Bevacqua R, Perrone S. COVID-19: relación entre enzima convertidora de angiotensina 2, sistema cardiovascular y respuesta inmune del huésped. Insuf Card. 2020;15(2):34-51.

González González F, Cortés Correa C, Peñaranda Contreras E. Manifestaciones cutáneas en pacientes con COVID-19: características clínicas y mecanismos fisiopatológicos postulados. Actas Dermo-Sifiliográficas. 2021;112(4):314-23. https://doi.org/10.1016/J.AD.2020.11.013

Shams S, Rathore SS, Anvekar P, Sondhi M, Kancherla N, Tousif S, et al. Maculopapular skin eruptions associated with Covid-19: A systematic review. Dermatol Ther. 2021;34(2):e14788. https://doi.org/10.1111/DTH.14788

Li M-Y, Li L, Zhang Y, Wang X-S. Expression of the SARS-CoV-2 cell receptor gene ACE2 in a wide variety of human tissues. Infect Dis Pov. 2020;9(1). https://doi.org/10.1186/S40249-020-00662-X

Xue X, Mi Z, Wang Z, Pang Z, Liu H, Zhang F. High Expression of ACE2 on Keratinocytes Reveals Skin as a Potential Target for SARS-CoV-2. J Invest Dermatol. 2021;141(1):206. https://doi.org/10.1016/J.JID.2020.05.087

Al-Benna S. Gene Expression of Angiotensin-Converting Enzyme 2 Receptor in Skin and the Implications for COVID-19. Adv Skin Wound Care. 2021;34(1):31-5. https://doi.org/10.1097/01.ASW.0000722748.73437.7D

Zhu R, Shi Y, Tan Y, Xiao R. ACE2 Expression on the Keratinocytes and SARS-CoV-2 Percutaneous Transmission: Are they Related? J Invest Dermatol. 2021;141(1):197. https://doi.org/10.1016/J.JID.2020.09.019

Jamshidi P, Hajikhani B, Mirsaeidi M, Vahidnezhad H, Dadashi M, Nasiri MJ. Skin Manifestations in COVID-19 Patients: Are They Indicators for Disease Severity? A Systematic Review. Front Med. 2021;8:634208. https://doi.org/10.3389/FMED.2021.634208

Kubanov AA, Deryabin DG. Skin manifestations in COVID-19 provide a clue for disease’s pathophysiology understanding. J Eur Acad Dermatol Venereol. 2021;35(1):e3-e4. https://doi.org/10.1111/JDV.16902

Zhang Y, Cao W, Jiang W, Xiao M, Li Y, Tang N, et al. Profile of natural anticoagulant, coagulant factor and anti-phospholipid antibody in critically ill COVID-19 patients. J Thromb Thrombolysis. 2020;50(3):580-6. https://doi.org/10.1007/S11239-020-02182-9

Li H, Liu L, Zhang D, Xu J, Dai H, Tang N, et al. SARS-CoV-2 and viral sepsis: observations and hypotheses. Lancet. 2020;395(10235):1517-20. https://doi.org/10.1016/S0140-6736(20)30920-X

Gianotti R, Veraldi S, Recalcati S, Cusini M, Ghislanzoni M, Boggio F, et al. Cutaneous clinico-pathological findings in three covid-19-positive patients observed in the metropolitan area of Milan, Italy. Acta Dermato-Venereologica. 2020;100(8):adv00126. https://doi.org/10.2340/00015555-3490

Campo-Slebi I, Meza-Corso MF, Cárdenas P, Castro-Ayarza JR, González C, Cortés C, et al. COVID-19 in patients with psoriasis: A Latin American case series. JAAD Int. 2021;5:96-7. https://doi.org/10.1016/j.jdin.2021.09.001

Kolivras A, Dehavay F, Delplace D, Feoli F, Meiers I, Milone L, et al. Coronavirus (COVID-19) infection–induced chilblains: A case report with histopathologic findings. JAAD Case Rep. 2020;6(6):489-92. https://doi.org/10.1016/J.JDCR.2020.04.011

Rajan B, Kumar-M P, Bhardwaj A. The trend of cutaneous lesions during COVID-19 pandemic: lessons from a meta-analysis and systematic review. Int J Dermatol. 2020;59(11):1358-70. https://doi.org/10.1111/IJD.15154

Jones VG, Mills M, Suarez D, Hogan C, Yeh D, Segal J, et al. COVID-19 and Kawasaki Disease: Novel Virus and Novel Case. Hosp Pediatr. 2020;10(6):537-40. https://doi.org/10.1542/HPEDS.2020-0123

Mahé A, Birckel E, Krieger S, Merklen C, Bottlaender L. A distinctive skin rash associated with coronavirus disease 2019? J Eur Acad Dermatol Venereol. 2020;34(6):e246-e247. https://doi.org/10.1111/JDV.16471

Sachdeva M, Gianotti R, Shah M, Bradanini L, Tosi D, Veraldi S, et al. Cutaneous manifestations of COVID-19: Report of three cases and a review of literature. J Dermatol Sci. 2020;98(2):75-81. https://doi.org/10.1016/J.JDERMSCI.2020.04.011

Mirza FN, Malik AA, Omer SB, Sethi A. Dermatologic manifestations of COVID-19: a comprehensive systematic review. Int J Dermatol. 2021;60(4):418-50. https://doi.org/10.1111/IJD.15168

Conforti C, Dianzani C, Agozzino M, Giuffrida R, Marangi G, di Meo N, et al. Cutaneous Manifestations in Confirmed COVID-19 Patients: A Systematic Review. Biology. 2020;9(12):1-28. https://doi.org/10.3390/BIOLOGY9120449

Seirafianpour F, Sodagar S, Mohammad AP, Panahi P, Mozafarpoor S, Almasi S, et al. Cutaneous manifestations and considerations in COVID-19 pandemic: A systematic review. Dermatol Ther. 2020;33(6):e13986. https://doi.org/10.1111/DTH.13986

De Masson A, Bouaziz JD, Sulimovic L, Cassius C, Jachiet M, Ionescu M, et al. Chilblains is a common cutaneous finding during the COVID-19 pandemic: A retrospective nationwide study from France. J Am Acad Dermatol. 2020;83(2):667-70. https://doi.org/10.1016/j.jaad.2020.04.161

Hedou M, Carsuzaa F, Chary E, Hainaut E, Cazenave-Roblot F, Masson Regnault M. Comment on ‘Cutaneous manifestations in COVID-19: a first perspective’ by Recalcati S. J Eur Acad Dermatol Venereol. 2020;34(7):e299-e300. https://doi.org/10.1111/jdv.16519

Marzano AV, Genovese G, Fabbrocini G, Pigatto P, Monfrecola G, Piraccini B, et al. Varicella-like exanthem as a specific COVID-19–associated skin manifestation: Multicenter case series of 22 patients. J Am Acad Dermatol. 2020;83(1):280-5. https://doi.org/10.1016/j.jaad.2020.04.044

Askin O, Altunkalem RN, Altinisik DD, Uzuncakmak TK, Tursen U, Kutlubay Z. Cutaneous manifestations in hospitalized patients diagnosed as COVID-19. Dermatol Ther. 2020;33(6). https://doi.org/10.1111/dth.13896

Rubio-Muniz CA, Puerta-Peña M, Falkenhain-López D, Arroyo-Andrés J, Agud-Dios M, Rodriguez-Peralto J, et al. The broad spectrum of dermatological manifestations in COVID-19: clinical and histopathological features learned from a series of 34 cases. J Eur Acad Dermatol Venereol. 2020;34(10):e574-e576. https://doi.org/10.1111/jdv.16734

Méndez Maestro I, Peña Merino L, Udondo González del Tánago B, Aramburu González A, Orbea Sopeña A, Sánchez De Vicente J, et al. Skin manifestations in patients hospitalized with confirmed COVID-19 disease: a cross-sectional study in a tertiary hospital. Int J Dermatol. 2020;59(11):1353-7. https://doi.org/10.1111/ijd.15180

Morey-Olivé M, Espiau M, Mercadal-Hally M, Lera-Carballo E, García-Patos V. Cutaneous manifestations in the current pandemic of coronavirus infection disease (COVID 2019). Ann Pediatr. 2020;92(6):374-5. https://doi.org/10.1016/j.anpede.2020.04.002

Henry D, Ackerman M, Sancelme E, Finon A, Esteve E. Urticarial eruption in COVID-19 infection. J Eur Acad Dermatol Venereol. 2020;34(6):e244-e245. https://doi.org/10.1111/jdv.16472

Rivera-Oyola R, Koschitzky M, Printy R, Liu S, Stanger R, Golant A, et al. Dermatologic findings in 2 patients with COVID-19. JAAD Case Rep. 2020;6(6):537-9. https://doi.org/10.1016/j.jdcr.2020.04.027

van Damme C, Berlingin E, Saussez S, Accaputo O. Acute urticaria with pyrexia as the first manifestations of a COVID-19 infection. J Eur Acad Dermatol Venereol. 2020;34(7):e300-e301. https://doi.org/10.1111/jdv.16523

Lu S, Lin J, Zhang Z, Xiao L, Jiang Z, Chen J, et al. Alert for non-respiratory symptoms of coronavirus disease 2019 patients in epidemic period: A case report of familial cluster with three asymptomatic COVID-19 patients. J Med Virol. 2021;93(1):518-21. https://doi.org/10.1002/jmv.25776

Fernandez-Nieto D, Ortega-Quijano D, Jimenez-Cauhe J, Burgos-Blasco P, De Perosanz-Lobo D, Suarez-Valle A, et al. Clinical and histological characterization of vesicular COVID-19 rashes: a prospective study in a tertiary care hospital. Clin Exp Dermatol. 2020;45(7):872-5. https://doi.org/10.1111/ced.14277

Mahé A, Birckel E, Merklen C, Lefèbvre P, Hannedouche C, Jost M, et al. Histology of skin lesions establishes that the vesicular rash associated with COVID-19 is not ‘varicella-like’. J Eur Acad Dermatol Venereol. 2020;34(10):e559-e561. https://doi.org/10.1111/jdv.16706

Keshavarzi A, Mohammadi AA, Ayaz M, Javanmardi F, Hoghoughi M, Yeganeh B, et al. Cutaneous Vesicular of COVID-19 in Two Burn Patients. World J Plast Surg. 2020;9(3):331-8. https://doi.org/10.29252/wjps.9.3.331

García-Gil MF, Monte Serrano J, García García M, Barra Borao V, Matovelle Ochoa C, Ramirez-Lluch M, et al. Acral purpuric lesions associated with coagulation disorders during the COVID-19 pandemic. Int J Dermatol. 2020;59(9):1151-2. https://doi.org/10.1111/ijd.15041

Bouaziz JD, Duong TA, Jachiet M, Velter C, Lestang P, Cassius C, et al. Vascular skin symptoms in COVID-19: a French observational study. J Eur Acad Dermatol Venereol. 2020;34(9):e451-e452. https://doi.org/10.1111/jdv.16544

Recalcati S, Barbagallo T, Frasin LA, Prestinari F, Cogliardi A, Provero M, et al. Acral cutaneous lesions in the time of COVID-19. J Eur Acad Dermatol Venereol. 2020;34(8):e346-e347. https://doi.org/10.1111/jdv.16533

Alramthan A, Aldaraji W. Two cases of COVID-19 presenting with a clinical picture resembling chilblains: first report from the Middle East. Clin Exp Dermatol. 2020;45(6):746-8. https://doi.org/10.1111/ced.14243

Pavone P, Marino S, Marino L, Cacciaguerra G, Guarneri C, Nunnari G, et al. Chilblains-like lesions and SARS-CoV-2 in children: An overview in therapeutic approach. Dermatol Ther. 2021;34(1):2-6. https://doi.org/10.1111/dth.14502

Landa N, Mendieta-Eckert M, Fonda-Pascual P, Aguirre T. Chilblain-like lesions on feet and hands during the COVID-19 Pandemic. Int J Dermatol. 2020;59(6):739-43. https://doi.org/10.1111/ijd.14937

Docampo-Simón A, Sánchez-Pujol MJ, Juan-Carpena G, Palazón-Cabanes J, Vergara-De Caso E, Berbegal L, et al. Are chilblain-like acral skin lesions really indicative of COVID-19? A prospective study and literature review. J Eur Acad Dermatol Venereol. 2020;34(9):e445-e447. https://doi.org/10.1111/jdv.16665

Cappel M, Cappel J, Wetter D. Pernio (Chilblains), SARS-CoV-2, and COVID Toes Unified Through Cutaneous and Systemic Mechanisms. Mayo Clin Proc. 2020;96(4):989-1005. https://doi.org/10.1016/j.mayocp.2021.01.009

Kluger N. Livedoid vasculopathy. Forum for N Dermato-Venerol. 2018;23(1):3-5. https://doi.org/10.5005/jp/books/13043_34

Gottlieb M, Long B. Dermatologic manifestations and complications of COVID-19. Am J Emerg Med. 2020;38(9):1715-21. https://doi.org/10.1016/j.ajem.2020.06.011

Tang N, Li D, Wang X, Sun Z. Abnormal coagulation parameters are associated with poor prognosis in patients with novel coronavirus pneumonia. J Thromb Haemostasis. 2020;18(4):844-7. https://doi.org/10.1111/jth.14768

Naderi-Azad S, Vender R. Lessons From the First Wave of the Pandemic: Skin Features of COVID-19 Can Be Divided Into Inflammatory and Vascular Patterns. J Cut Med Surg. 2021;25(2):169-76. https://doi.org/10.1177/1203475420972343

Wambier CG, Vaño-Galván S, McCoy J, Shapiro J, Pérez B, Goren A, et al. Androgenetic alopecia present in the majority of patients hospitalized with COVID-19: The “Gabrin sign.” J Am Acad Dermatol. 2020;83(2):680-2. https://doi.org/10.1016/j.jaad.2020.05.079

Müller Ramos P, Ianhez M, Amante Miot H. Alopecia and grey hair are associated with COVID-19 Severity. Exp Dermatol. 2020;29(12):1250-2. https://doi.org/10.1111/exd.14220

Wambier C, Goren A. Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection is likely to be androgen mediated. J Am Acad Dermatol. 2020;83(1):308-9. https://doi.org/10.1016/j.jaad.2020.04.032

Berbert Ferreira S, Gavazzoni Dias MFR, Berbert Ferreira R, Neves Neto AC, Trüeb RM, Lupi O. Rapidly progressive alopecia areata totalis in a COVID-19 patient, unresponsive to tofacitinib. J Eur Acad Dermatol Venereol. 2021;35(7):e411-e412. https://doi.org/10.1111/jdv.17170

Rizzetto G, Diotallevi F, Campanati A, Radi G, Bianchelli T, Molinelli E, et al. Telogen effluvium related to post severe Sars-Cov-2 infection: Clinical aspects and our management experience. Dermatol Ther. 2021;34(1):1-6. https://doi.org/10.1111/dth.14547

Shanshal M. COVID-19 related anagen effluvium. J Dermatol Treat. 2020;0(0):1-2. https://doi.org/10.1080/09546634.2020.1792400

Moreno-Arrones OM, Lobato-Berezo A, Gomez-Zubiaur A, Arias-Santiago S, Saceda-Corralo D, Bernardez-Guerra C, et al. SARS-CoV-2-induced telogen effluvium: a multicentric study. J Eur Acad Dermatol Venereol. 2021;35(3):e181-e183. https://doi.org/10.1111/jdv.17045

Natalello G, Luca G De, Gigante L, Campochiaro C, De Lorenzis E, Verardi L, et al. Nailfold capillaroscopy findings in patients with coronavirus disease 2019: Broadening the spectrum of COVID-19 microvascular involvement. Microvasc Res. 2021;133:104071. https://doi.org/10.1016/j.mvr.2020.104071

Alobaida S, Lam JM. Beau lines associated with COVID-19. CMAJ. 2020;192(36):E1040. https://doi.org/10.1503/cmaj.201619

Ide S, Morioka S, Inada M, Ohmagari N. Beau’s lines and leukonychia in a COVID-19 patient. Int Med. 2020;59(24):3259. https://doi.org/10.2169/internalmedicine.6112-20

Aslan Kayıran M, Cebeci F, Erdemir VA, Aksoy H, Akdeniz N, Gürel MS. Fluorescence of nails and hair on Wood’s lamp examination in Covid pandemic; undefined effect of Favipiravir in humans. Dermatol Ther. 2021;34(1):1-4. https://doi.org/10.1111/dth.14740

Dziedzic A, Wojtyczka R. The impact of coronavirus infectious disease 19 (COVID-19) on oral health. Oral Dis. 2021;27(S3):703-6. https://doi.org/10.1111/odi.13359

Paradowska-Stolarz AM. Oral manifestations of covid-19: Brief review. Dental Med Problems. 2021;58(1):123-6. https://doi.org/10.17219/dmp/131989

Amorim dos Santos J, Normando AGC, Carvalho da Silva RL, Cembranel A, Santos A, Silva E, et al. Oral mucosal lesions in a COVID-19 patient: New signs or secondary manifestations? International J Infect Dis. 2020;97:326-8. https://doi.org/10.1016/j.ijid.2020.06.012

Nuno-Gonzalez A, Martin-Carrillo P, Magaletsky K, Rios M, Herranz Mañas C, Artigas Almazan J, et al. Prevalence of mucocutaneous manifestations in 666 patients with COVID-19 in a field hospital in S pain: oral and palmoplantar findings. Br J Dermatol. 2021;184(1):184-5. https://doi.org/10.1111/bjd.19564

Amorim dos Santos J, Normando AGC, Carvalho da Silva RL, Acevedo A, De Luca Canto G, Sugaya N, et al. Oral Manifestations in Patients with COVID-19: A Living Systematic Review. J Dental Res. 2021;100(2):141-54. https://doi.org/10.1177/0022034520957289

Cómo citar

1.
Botello H, Zamudio Barrientos A, Gahona Naranjo ME. Manifestaciones dermatológicas por Covid-19 y su aporte en la comprensión de la enfermedad. rev. asoc. colomb. dermatol. cir. dematol. [Internet]. 19 de septiembre de 2022 [citado 19 de julio de 2024];30(3):189-203. Disponible en: https://revista.asocolderma.org.co/index.php/asocolderma/article/view/1641

Descargas

Los datos de descargas todavía no están disponibles.

Descargas

Publicado

2022-09-19

Cómo citar

1.
Botello H, Zamudio Barrientos A, Gahona Naranjo ME. Manifestaciones dermatológicas por Covid-19 y su aporte en la comprensión de la enfermedad. rev. asoc. colomb. dermatol. cir. dematol. [Internet]. 19 de septiembre de 2022 [citado 19 de julio de 2024];30(3):189-203. Disponible en: https://revista.asocolderma.org.co/index.php/asocolderma/article/view/1641

Número

Sección

Revisión de la literatura
Crossref Cited-by logo
QR Code
Estadísticas de artículo
Vistas de resúmenes
Vistas de PDF
Descargas de PDF
Vistas de HTML
Otras vistas

Algunos artículos similares: